Effect of SGLT-2 Inhibitors on Non-alcoholic Fatty Liver Disease among Patients with Type 2 Diabetes Mellitus: Systematic Review with Meta-analysis and Trial Sequential Analysis of Randomized Clinical Trials

OBJECTIVES: Non-alcoholic fatty liver disease (NAFLD) or non-alcoholic steatohepatitis (NASH) is a common problem associated with obesity and type 2 diabetes mellitus (T2DM). There have been anecdotal reports of the efficacy of sodium-glucose cotransporter 2 inhibitors (SGLT2Is) in improving liver f...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Kai Wei, Devaraj, Navin Kumar, Ching, Siew Mooi, Veettil, Sajesh K, Hoo, Fan Kee, Deuraseh, Inas, Soo, Man Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: OMJ 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246653/
https://www.ncbi.nlm.nih.gov/pubmed/34239714
http://dx.doi.org/10.5001/omj.2021.62

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246653/
https://www.ncbi.nlm.nih.gov/pubmed/34239714
http://dx.doi.org/10.5001/omj.2021.62

Ejemplares similares